OXFORD - Pharmaceutical companies have agreed to a new scheme that will cut by 4.5 percent the price the British National Health Service (NHS) pays for existing branded prescription drugs, and put a 15-month freeze on price increases.

Industry reluctantly agreed to the cuts in return for a package of profit and export incentives.